Does BELATACEPT Cause Off label use? 304 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 304 reports of Off label use have been filed in association with BELATACEPT (NULOJIX). This represents 8.9% of all adverse event reports for BELATACEPT.
304
Reports of Off label use with BELATACEPT
8.9%
of all BELATACEPT reports
42
Deaths
124
Hospitalizations
How Dangerous Is Off label use From BELATACEPT?
Of the 304 reports, 42 (13.8%) resulted in death, 124 (40.8%) required hospitalization, and 17 (5.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELATACEPT. However, 304 reports have been filed with the FAERS database.
What Other Side Effects Does BELATACEPT Cause?
Death (206)
Transplant rejection (178)
Cytomegalovirus infection (142)
Drug ineffective (142)
Product storage error (142)
Acute kidney injury (137)
Covid-19 (129)
Hospitalisation (123)
Kidney transplant rejection (97)
Intentional product use issue (83)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BELATACEPT Alternatives Have Lower Off label use Risk?
BELATACEPT vs BELIMUMAB
BELATACEPT vs BELINOSTAT
BELATACEPT vs BELUMOSUDIL
BELATACEPT vs BELVIQ
BELATACEPT vs BELZUTIFAN